申请人:Teshima Koji
公开号:US20050119308A1
公开(公告)日:2005-06-02
The present invention has been made based on the finding that a compound acting on the ORL-1 receptor as an agonist acts as a non-photic entrainment factor, and advances the circadian rhythm phase, and provides a novel therapeutic agent for a sleep disorder such as circadian rhythm sleep disorder, more particularly, an agent for the prophylaxis and/or treatment of a sleep disorder, which contains an ORL-1 receptor agonist, and a novel compound useful as such agent for the prophylaxis and/or treatment.
本发明是基于发现得出的,即作用于ORL-1受体的化合物作为激动剂时,作为非光周期性调节因子,可以提前昼夜节律阶段,并提供一种新的治疗药物,用于治疗睡眠障碍,如昼夜节律睡眠障碍,更具体地说,是一种用于预防和/或治疗睡眠障碍的药物,其中包含ORL-1受体激动剂,并提供了一种作为该药物预防和/或治疗的有用化合物。